Nisha Rathode (Editor)

James Haim I Bicher

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Covid-19
Profession  Radiation Oncologist

Name  James I.
James Haim I. Bicher
Born  May 12, 1937 (age 78) (1937-05-12) San Cristobal, Santa Fe, Argentina

James Haim I. Bicher, M.D. (born May 12, 1937 in San Cristóbal, Santa Fe, Argentina) is an American radiation oncologist. He is a pioneer in the clinical use of Hyperthermia combined with low dose (protracted) radiation therapy (thermoradiotherapy). He is a founder and past president of ISOTT, North American Hyperthermia Group, and the American Society of Clinical Hyperthermic Oncology. Dr. Bicher was a student of Nobel Prize winner Bernardo Alberto Houssay, and one of the pioneer contributors to the basic principles that allowed later development of Plavix.

Dr. Bicher is the founder and a director of Bicher Cancer Institute. Prior to this role his career included the following positions: Chief of Hyperthermic Clinic at Western Tumor Medical Group in Van Nuys, California, Director of NonIonizing Radiation Cancer Treatment Center at Henry Ford Hospital in Detroit, Michigan, and Associate Chief of Department of Radiation Medicine at Roswell Park Cancer Institute in Buffalo, New York.

He currently serves as the North American Vice-President of the International Clinical Hyperthermia Society and Senior Consultant at the Beritashvili Institute of Physiology, Georgian Academy of Sciences, Georgia.

References

James Haim I. Bicher Wikipedia


Topics
 
B
i
Link
H2
L